EIGER BIOPHARMACEUTICALS INC — Form D
EIGER BIOPHARMACEUTICALS INC of Santa Clara, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-04-27. The offering totals $5.0M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-04-27
- Form: D
- Accession: 0001454815-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $3.5M
- Remaining: $1.4M
- Investors: 4
- Date of first sale: 2011-04-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-158936
Issuer
- Name: EIGER BIOPHARMACEUTICALS INC
- CIK: 0001454815
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 1115 Lafayette St., Santa Clara, CA, 95050
- Phone: 650-804-8553
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Paul Truex | Director | Santa Clara, CA |
| Glen Sato | Executive Officer | Santa Clara, CA |
| Keith Vendola | Executive Officer | St. Louis, MO |
| Nina Kjellson | Director | Santa Clara, CA |
| Thomas Dietz | Director | Research Triangle Park, NC |
| David Cory | Director | Santa Clara, CA |
| David Cory | Executive Officer | Santa Clara, CA |
| Ed Engleman | Director | Santa Clara, CA |
| Jeffrey Glenn | Director | Santa Clara, CA |
| Wenjin Yang | Executive Officer | Redwood City, CA |
Other filings by this issuer (9)
More